levi-04
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 28, 2017 (NCT03227796)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05618782 | Phase 2 | Oct 17, 2022 | Levicept, Nordic Bioscience |
| NCT03227796 | Phase 1 | Jul 28, 2017 | Hammersmith Medicines Research, Levicept |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Levicept | For profit | 2 | 2 | 2 | 2017 |
| Hammersmith Medicines Research | For profit | 1 | 0 | 1 | 2017 |
| Nordic Bioscience | For profit | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1